News

KFF Health News on MSN12d
CDC Staffing Upheaval Disrupts HIV Projects and Wastes Money, Researchers Say
Researchers laid off in April were putting the finishing touches on in-depth HIV surveys that guide treatment and prevention.
Healthline2d
FDA Approves 'Breakthrough' Twice-Yearly Injection to Prevent HIV
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Discover Magazine on MSN6d
FDA Approves Breakthrough HIV Drug, but It Could Be Hard to Access
Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
CDC worker on confusion and uncertainty in being recalled
An HIV expert spoke to 11Alive about being among those who were on leave and are now being recalled at the CDC.
The Well News on MSN7d
FDA Approves Gilead's Twice-Yearly Injection for HIV Prevention
WASHINGTON - The Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...